Chengdu Kanghua Biological Products (300841) — Capital Reinvestment Ratio
Chengdu Kanghua Biological Products (300841) has a Capital Reinvestment Ratio of 0.16x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥92.89 Million) in capital expenditures (CN¥14.49 Million). See Chengdu Kanghua Biological Products balance sheet quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Chengdu Kanghua Biological Products Capital Reinvestment Ratio (2015–2024)
This chart tracks Chengdu Kanghua Biological Products's Capital Reinvestment Ratio across 10 annual periods. Check 300841 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Chengdu Kanghua Biological Products (2015–2024)
Year-by-year Capital Reinvestment Ratio for Chengdu Kanghua Biological Products from 2015 to 2024. For live market cap and broader valuation context, see market value of Chengdu Kanghua Biological Products.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.25x | CN¥572.24 Million | CN¥144.30 Million | ▼ -8.0% |
| 2023 | 0.27x | CN¥573.98 Million | CN¥157.27 Million | ▼ -87.3% |
| 2022 | 2.15x | CN¥194.99 Million | CN¥419.23 Million | ▼ -11.0% |
| 2021 | 2.42x | CN¥130.33 Million | CN¥314.94 Million | ▲ +558.3% |
| 2020 | 0.37x | CN¥369.56 Million | CN¥135.67 Million | ▲ +179.1% |
| 2019 | 0.13x | CN¥182.73 Million | CN¥24.04 Million | ▼ -78.2% |
| 2018 | 0.60x | CN¥57.35 Million | CN¥34.58 Million | ▲ +1096.9% |
| 2017 | 0.05x | CN¥89.96 Million | CN¥4.53 Million | ▼ -92.8% |
| 2016 | 0.70x | CN¥2.64 Million | CN¥1.86 Million | ▲ +48.7% |
| 2015 | 0.47x | CN¥6.51 Million | CN¥3.07 Million | — |